IP Verse

Breuer, Markus opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Breuer, Markus

Patent Number:
EP3370770
Title:
Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their Uses
Applicant:
JANSSEN BIOTECH, INC.
Opposition Date:
Oct 20, 2021
Patent Number:
EP3095463
Title:
Methods For Treating Progressive Multiple Sclerosis
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Jun 9, 2021
Patent Number:
EP2809773
Title:
Process Of Modulating Man5 And/Or Afucosylation Content Of Glycoprotein Composition
Applicant:
DR. REDDY'S LABORATORIES LIMITED
Opposition Date:
Jun 2, 2021
Patent Number:
EP3351620
Title:
Metabolically Optimized Cell Culture
Applicant:
REGENERON PHARMACEUTICALS, INC.
Opposition Date:
Jun 2, 2021
Patent Number:
EP3147355
Title:
Method For Preparing Aqueous Solution Containing Culture Medium And Chelating Agent
Applicant:
KYOWA HAKKO KIRIN CO., LTD.
Opposition Date:
Apr 22, 2021
Patent Number:
EP3121266
Title:
Oligopeptide-Free Cell Culture Media
Applicant:
BAXALTA GMBH
Opposition Date:
Nov 26, 2020
Patent Number:
EP3294856
Title:
Process Control System For Regulating And Controlling A Modular Plant For Manufacturing Biopharmaceutical And Biological Macromolecular Products
Applicant:
BAYER AKTIENGESELLSCHAFT
Opposition Date:
Jun 18, 2020
Patent Number:
EP2841561
Title:
Cell Culture Compositions And Methods For Polypeptide Production
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Oct 16, 2019
Patent Number:
EP2949666
Title:
Human Anti-Alpha-Synuclein Antibodies
Applicant:
BIOGEN INTERNATIONAL NEUROSCIENCE GMBH
Opposition Date:
Sep 17, 2019
Patent Number:
EP3250185
Title:
Ophthalmic Suspension Composition
Applicant:
BAUSCH & LOMB INCORPORATED
Opposition Date:
Sep 5, 2019

Competitors of Breuer, Markus

F. HOFFMANN-LA ROCHE AG

REGENERON PHARMACEUTICALS, INC.

BAUSCH & LOMB INCORPORATED

Want to track Breuer, Markus?

Feel free to send us a message here and we will get back to you